オプション
〜
検索条件をクリア

書籍詳細

未契約
書籍名 MRS of the Brain and Neurological Disorders
出版社 先端医療技術研究所
発行日 2000-01-01
著者
  • Akihiro Igata,M.D.(Supervisors)
  • Tetsuhiko Asakura,M.D.(Supervisors)
  • Toshiro Fujimoto,M.D.(Editor & Contributor)
ISBN 084930346x
ページ数 353
版刷巻号
分野
閲覧制限 未契約

「脳神経疾患のMRS」英語版

目次

  • 表紙
    閲覧
  • Contributors
    閲覧
  • Collaborators
    閲覧
  • Preface
    閲覧
  • Words of Recommendation
    閲覧
  • A Message of Congratulation on the Publication of MRS of the Brain and Neurological Disorders
    閲覧
  • Preface to the First Edition
    閲覧
  • CONTENTS
    閲覧
  • Pulse Sequence and Informed Consent
    閲覧
  • Introduction
    P.1閲覧
  • PART I BACKGROUND AND THEORETICAL BASIS
    P.9閲覧
    • Chapter 1 History of MRS
      • 1.1 Magnet and Physical Background
      • 1.2 Major Accomplishments Concerning MRS and MRI
    • Chapter 2 Basic Principles of MRS
      • 2.1 Principles of measurements
        • 2.1.1 RF coil
        • 2.1.2 Localization
          • (1) Single-voxel method
          • (2) Multivoxel method
          • (3) Comparison of the single-voxel and multivoxel methods
        • 2.1.3 Water suppression
        • 2.1.4 Reception of signals and RF detection
      • 2.2 Post-processing
        • 2.2.1 Automatic baseline correction for 31P-CSI
          • (1) Baseline correction
          • (2) Theory
            • Complete spectrum
            • Observed spectrum
            • Baseline-correction spectrum
            • Peak parameters
            • Estimation scheme of values of peak parameters
          • (3) Simulation and discussion
          • (4) Features of the baseline correction
        • 2.2.2 Various post-processing techniques
          • (1) Apodization
          • (2) Phase correction
            • Constant phase correction
            • Linear phase correction
          • (3) Curve fitting
      • 2.3 Factors restricting measurements
        • 2.3.1 The sensitivity of the MRS involving biological samples
          • (1) The nuclear sensitivities of various elements
          • (2) The SNR of MRS studies
          • (3) The upper limit of achievable MRS sensitivities
        • 2.3.2 Various limitation factors
          • (1) Spatial resolution
          • (2) Spatial contamination
          • (3) Temporal resolution
          • (4) Delay time
          • (5) Eddy currents
      • 2.4 Factors affecting the performance
        • 2.4.1 Selection of the RF coil
        • 2.4.2 Fat suppression
        • 2.4.3 Water suppression
        • 2.4.4 Local shim
      • 2.5 Prospects for the future
        • 2.5.1 Improvements in the RF coil technology
        • 2.5.2 Quantification
    • Chapter 3 Understanding Spectra of 31P MRS and 1H MRS
      • 3.1 Major parameters of MRS
        • 3.1.1 Chemical shift
        • 3.1.2 Spin-spin coupling
        • 3.1.3 Relaxation mechanisms
          • (1) Spin-lattice(longitudinal)relaxation
          • (2) Spin-spin(transverse)relaxation
          • (3) Dipole-dipole relaxation mechanism of protons in liquids and variation of T1 and T2 with correlation time(Tc)
        • 3.1.4 Nuclear Overhauser Effect(NOE) and proton decoupling
      • 3.2 31P MRS
        • 3.2.1 Resonance of PME
        • 3.2.2 Resonance of PDE
        • 3.2.3 Phospholipids
        • 3.2.4 Resonance of ATP, Pi, and PCr
      • 3.3 1H MRS
        • 3.3.1 Resonance of NAA(N-acetylaspartate)
        • 3.3.2 Resonance of Cr(creatine and phosphocreatine)
        • 3.3.3 Resonance of Cho(choline containing compounds)
        • 3.3.4 Resonance of lactate
        • 3.3.5 Resonance of NAAG(N-acetylaspartylglutamate)
        • 3.3.6 Resonance of ml(myo-inositol)
        • 3.3.7 Resonance of Glx(glutamate and glutamine)
        • 3.3.8 Resonance of GABA(γ-aminobutyric acid)
    • Chapter 4 MRS of Healthy Individuals
      • 4.1 31P MRS by CSI
        • 4.1.1 Examples of the 31P spectrum of a healthy individual 31P spectra of voxels 1-10
        • 4.1.2 Examples of the 31P spectrum in a healthy individual 31P spectra of voxels 11-13
        • 4.1.3 Examples of the 31P spectrum in a healthy individual 31P spectra of voxels 14 and 15
        • 4.1.4 Examples of the 31P spectrum in a healthy individual 31P spectra obtained by averaging over voxels
        • 4.1.5 Mean ratios of peaks of the 31P spectrum of healthy individuals
        • 4.1.6 Examples of the metabolite image and contour map of a healthy individual
      • 4.2 1H MRS by the single voxel method
        • 4.2.1 Examples of the 1H spectrum of the basal ganglia in a healthy individual
        • 4.2.2 Mean peak ratios in the 1H spectrum of the basal ganglia regions in healthy individuals
        • 4.2.3 Examples of 1H spectra in mesial temporal lobes in a healthy individual
        • 4.2.4 Mean peak ratios in 1H spectra in mesial temporal lobes in healthy individuals
  • PART II CLINICAL APPLICATIONS
    P.87閲覧
    • Chapter 5 Brain Tumors
      • 5.1 Characteristics of the spectrum
        • 5.1.1 31P MRS of brain tumors
          • (1) Quantity of phosphorus compounds
          • (2) Intratumoral pH
          • (3) 31P MRS as a means to monitor therapeutic effects on brain tumors
        • 5.1.2 1H MRS of brain tumors
      • 5.2 Cases(1-21)
        • 1: Pituitary adenoma
        • 2: Pituitary adenoma
        • 3: Meningioma
        • 4: Meningioma
        • 5: Meningioma
        • 6: Neurinoma
        • 7: Epidermoid
        • 8: Astrocytoma(grade I)
        • 9: Astrocytoma(grade II) Evaluations before and after ACNU chemotherapy
        • 10: Astrocytoma(grade III)
        • 11: Astrocytoma(grade III)
        • 12: Astrocytoma(grade III)
        • 13: Astrocytoma(grade IV)
        • 14: Glioblastoma
        • 15: Glioblastoma
        • 16: Oligodendroglioma
        • 17: Metastatic brain tumor(from the rectum)
        • 18: Metastatic brain tumor(from the lung)
        • 19: Metastatic brain tumor(from the lung)
        • 20: Chondrosarcoma
        • 21: Mucocele
      • 5.3 Evaluation of the effects of radiotherapy and chemotherapy on brain tumors
      • 5.4 Evaluation of the effects of radiotherapy for brain tumors on normal brain tissue
    • Chapter 6 Cerebral Infarction
      • 6.1 Characteristics of the spectrum
      • 6.2 Cases(24-35)
        • 24: 5 hours and 1 year after the stroke(Cerebral infarction of the left and right occipital lobes)
        • 25: 2 and 7 days after the stroke(Cerebral infarction of the right temporal and occipital lobes)
        • 26: 2 days after the stroke(Cerebral infarction of the right temporal lobe)
        • 27: 2 days after the stroke(Cerebral infarction of the left frontal and temporal lobes)
        • 28: 3 days after the stroke(Cerebral infarction of the left temporal lobe)
        • 29: 6 days after the stroke(Cerebral infarction of the right frontal and temporal lobes)
        • 30: 7 days after the stroke(Cerebral infarction of the right frontal lobe)
        • 31: 7 days after the stroke(Cerebral infarction in a medial part of the right occipital lobe)
        • 32: 11 weeks after the stroke(Cerebral infarction of the right temporal lobe)
        • 33: 17 months after the stroke(Cerebral infarction of the left temporal lobe)
        • 34: 6 years after the stroke(Cerebral infarction of the left temporal lobe)
        • 35: Course of 31P MRS of cerebral infarction. A summary of 12 cases
    • Chapter 7 Cerebral Arteriovenous Malformation(AVM), Moya Moya Disease
      • 7.1 Characteristics of the spectrum
      • 7.2 Cases(36-40)
        • 36: AVM of the right parietal lobe
        • 37: AVM of the right frontal lobe
        • 38: AVM of the left frontal lobe
        • 39: Moya Moya disease(the blood flow on the right side is maintained due to a bypass operation performed 7 years before)
        • 40: Moya Moya disease
    • Chapter 8 Intracerebral Hemorrhage
      • 8.1 Characteristics of the spectrum
      • 8.2 Cases(41-53)
        • 41: on the day of the stroke(hemorrhage of the left thalamus)
        • 42: 1 day after the stroke(hemorrhage of the right thalamus)
        • 43: 1 day after the stroke(hemorrhage of the left thalamus)
        • 44: 2 days after the stroke(subcortical hemorrhage of the left frontal lobe)
        • 45: 2 days after the stroke(subcortical hemorrhage of the right temporal and parietal lobes)
        • 46: 3 days after the stroke(hemorrhage of the right putamen)
        • 47: 3 days after the stroke(hemorrhage of the right putamen)
        • 48: 4 days after the stroke(hemorrhage of the left putamen)
        • 49: 6 days after the stroke(hemorrhage of the left putamen)
        • 50: 7 days after the stroke(hemorrhage of the right thalamus)
        • 51: 9 days after the stroke(hemorrhage of the right putamen)
        • 52: 11 days after the stroke(hemorrhage of the left thalamus)
        • 53: 14 days after the stroke(hemorrhage of the right putamen)
    • Chapter 9 Dementia
      • 9.1 Characteristics of spectrum
        • 9.1.1 Dementia of Alzheimer type(AD)
        • 9.1.2 Pick's disease
        • 9.1.3 Multi-infarct dementia(MID)
        • 9.1.4 Binswanger's disease
      • 9.2 Cases(54-60)
        • 54: Dementia of Alzheimer type
        • 55: Dementia of Alzheimer type
        • 56: Dementia of Alzheimer type
        • 57-1: Probable Pick's disease(First 31P MRS study at 44 years)
        • 57-2: Probable Pick's disease(Second 31P MRS study at 44 years; 4 months after the first examination)
        • 57-3: Probable Pick's disease(Third 31P MRS study at 45 years; 10 months after the first examination)
        • 57-4: Probable Pick's disease(Fourth 31P MRS study at 45 years; 2 years after the first examination)
        • 57-5: Probable Pick's disease(1H and 31P spectra)
        • 58: Multi-infarct dementia
        • 59: Multi-infarct dementia
        • 60: Binswanger's disease
    • Chapter 10 Other Neurological Disorders
      • 10.1 Characteristics of the spectrum
        • 10.1.1 Multiple sclerosis(MS)
        • 10.1.2 Leukodystrophy
        • 10.1.3 Huntington's disease
      • 10.2 Cases(61-64)
        • 61: Multiple sclerosis
        • 62: Leukodystrophy
        • 63: Huntington's disease
        • 64: Huntington's disease
    • Chapter 11 Epilepsy
      • 11.1 Characteristics of the spectrum
      • 11.2 Cases(65-75)
        • 65: Symptomatic epilepsy
        • 66: Symptomatic epilepsy
        • 67: Symptomatic epilepsy
        • 68: Symptomatic epilepsy
        • 69: Symptomatic epilepsy
        • 70: Symptomatic epilepsy
        • 71: Absence(before and after corpus callosotomy)
        • 72: Symptomatic temporal lobe epilepsy. Complex partial seizures(focus on the left temporal lobe on EEG)
        • 73: Symptomatic temporal lobe epilepsy. Complex partial seizures(focus on the left temporal lobe on EEG)
        • 74: Symptomatic temporal lobe epilepsy. Complex partial seizures(focus on the left temporal lobe on EEG)
        • 75: Generalized seizures
    • Chapter 12 Psychiatric Disorders
      • 12.1 Characteristics of the spectrum
        • 12.1.1 Schizophrenia
        • 12.1.2 Depression
        • 12.1.3 Mania
        • 12.1.4 Alcoholism
      • 12.2 Cases(76-85)
        • 76: Schizophrenia(Disorganized type)
        • 77: Schizophrenia(Disorganized type)
        • 78: Schizophrenia(Disorganized type)
        • 79: Schizophrenia(Catatonic type)
        • 80: Bipolar 1 Disorder, Most Recent Episode Depressed
        • 81: Bipolar 1 Disorder, Most Recent Episode Depressed
        • 82: Bipolar 1 Disorder, Most Recent Episode Manic
        • 83: Alcohol Dependence(History of drinking: about 20 years)
        • 84: Alcohol-induced mood disorder(History of drinking: about 20 years)
        • 85: Alcohol Dependence(History of drinking: about 28 years)
  • Author Index
    P.323閲覧
  • Subject Index
    P.326閲覧

参考文献

表紙

P.3 掲載の参考文献

  • 1) Fujimoto, T.; Yokoyama, Y.; Fujimoto, A. et al. Study of endogenous psychoses using NMR-CT. Japanese Journal of Clinical Psychiatry 13:1517-1530; 1984.[Japanese]
  • 3) Fujimoto, T.; Tsuji, T.; Yokoyama, Y. et al. Study of dementia in the elderly using magnetic resonance (MR). Part I. -Measurement of proton spin lattice relaxation time (T1) using low field magnetic resonance. Japanese Journal of Psychiatric Treatment 3:897-908; 1988.[Japanese]
  • 4) Iriguchi, N.; Iwasaki, A.; Yamamoto, T. et al. Spectroscopy using 2 tesla whole body MRS (First report). Journal of NMR Medicine 5 (Suppl):108;1985.[Japanese]
  • 5) Miyazaki, T., Yamamoto, T.; Iriguchi, N. et al. Chemical shift imaging using SIDAC (Spectroscopic Imaging by Dephasing Amplitude Changing) method. Journal of NMR Medicine 6 (Suppl 2):125; 1986.[Japanese]
  • 6) Miyazaki, T.; Yamamoto, T.; Iriguchi, N. et al. Spectroscopic imaging by dephasing amplitude changing (SIDAC). In:Book of Abstracts. :Fifth Annual Meeting of the Society of Magnetic Resonance in Medicine, Vol.3. Montreal, Quebec, Canada:SMRM;1986:856-857.
  • 7) Miyazaki, T.; Yamamoto, T. ; Iriguchi, N. et al. Chemical shift imaging using SIDAC (Spectroscopic Imaging by Dephasing Amplitude Changing) method (Second report). Journal of NMR Medicine 7 (Suppl 1):105; 1987.[Japanese]
  • 9) Iriguchi, N.; Iwasaki, A.; Yamamoto, T. et al. Study of 19F NMR by 2 tesla MRS. Journal of NMR Medicine 6 (Suppl 1):143; 1986.[Japanese]
  • 10) Shimizu M.; Kobayashi, T.; Morimoto, H, et al. Cancer imaging using missile 19F MRI by anti-CEA antibody and 2T superconducting NMRsytem. Japanese Journal of Magnetic Resonance in Medicine 7 (Suppl 2):225; 1987.[Japanese]
  • 11) Iriguchi, N.; Iwasaki, A.; Yamamoto, T. et al, In vivo FTPA imaging using 2 tesla MRS. Journal of NMR Medicine 7 (Suppl 1):107; 1987.[Japanese]
  • 12) Hasegawa, J.;Iriguchi, N.; Ueshima, Y. et al. Human natural 13C-imaging. Japanese Journal of Magnetic Resonance in Medicine 7 (Suppl 2):224; 1987.[Japanese]
  • 13) Yamamoto, T.; Iriguchi, N.; Hasegawa, J. et al. Possibility of 13C brain imaging. Journal of NMR Medicine 7 (Suppl 1):109; 1987.[Japanese]
  • 14) Hasegawa, J.; Iriguchi, N.; Iwasaki, A. et al. Human natural 13C-MR imaging. Journal of NMR Medicine 7 (Suppl 1):110; 1987,[Japanese]
  • 15) Iriguchi, N.; Hasegawa, J.; Miyazaki, T. et al. P-31 magnetic resonance imaging, Japanese Journal of Magnetic Resonance in Medicine 7 (Suppl 2):228; 1987.[Japanese]
  • 16) Yamai, S.; Iriguchi, N.; Yamamoto, T, et al. In vivo real time 31P spectroscopy using 2 tesla whole body system. Journal of NMR Medicine 6 (Suppl 2):232; 1986.[Japanese]
  • 17) Yamai, S.; Iriguchi, N.; Yamamoto, T. et al. In vivo real time 31P spectroscopy using 2 tesla whole body system (Second report). Journal of NMR Medicine 7 (Suppl 1):136; 1987,[Japanese]
  • 18) Hasegawa, J.; Iwasaki, A.; Iriguchi, N. et al. Bioimaging using 1H gated decoupling method. Journal of NMR Medicine 6 (Suppl 2):123; 1986.[Japanese]
  • 19) Ueshima, Y.; Hasegawa, J.; Iriguchi, N. et al. Fundamental study of Tailored solvent suppression pulse. Journal of NMR Medicine 6 (Suppl 2):130; 1986.[Japanese]
  • 20) Yamamoto, T.; Yamai, S.; Iriguchi, N. et al. Absolute evaluation of S/N and quantification of limit. Journal of NMR Medicine 6 (Suppl 2):132; 1986.[Japanese]
  • 21) Hasegawa, J.; Ueshima, Y.; Iriguchi, N. et al. 2 tesla whole body imaging. Journal of NMR Medicine 6 (Suppl 2):197; 1986.[Japanese]
  • 22) Yamamoto, T.; Hikida, K.; Ueshima, Y. et al. Double speed imaging. Journal of NMR Medicine 7 (Suppl 1):96; 1987.[Japanese]
  • 23) Hikida, K.; Yamamoto, T,; Ueshima, Y. et al. Enlarged imaging of local region. Journal of NMR Medicine 7 (Suppl 1):101; 1987.[Japanese]
  • 24) Hikida, K.; Iriguchi, N.; Yamamoto, T. et al. Study of inclination of static magnetic field using strong magnetic. Journal of NMR Medicine 7 (Suppl 1):102; 1987,[Japanese]
  • 25) Ueshima, Y.; Hasegawa, J.; Yamamoto, T. et al Volume-Selected Spectroscopy ushng Tailored pulse. Journal of NMR Medicine 7 (Suppl 1):138; 1987.[Japanese]
  • 26) Iriguchi, N.; Yamai, S.; Hikida, K. et al. Localized MR spectroscopy using inclination of static magnetic field. Journal of NMR Medicine 7 (Suppl 1):139;1987.[Japanese]
  • 27) Hikida, K.; Iriguchi, N.; Yamamoto, T. et al. Study of inclination of static magnetic field using strong magnetic (Second report). Japanese Journal of Magnetic Resonance in Medicine 7 (Suppl 2):175; 1987.[Japanese]
  • 28) Miyazaki, T.; lriguchi, N.; Ueshima, Y, et al. Speed analyzing imaging of flow. Japanese Journal of Magnetic Resonance in Medicine 7 (Suppl 2):133;1987.[Japanese]
  • 29) Ueshima, Y. Volume-selected spectroscopy. Japanese Journal of Magnetic Resonance in Medicine 7:3-23; 1987.[Japanese]
  • 30) Yamamoto, T. Chemical shift imaging. Journal of NMR Medicine 6:221-239; 1987.[Japanese]
  • 31) Yamamoto, T.; Yamai, S. Iriguchi, N. et al. An estimation scheme for the S/N of coil, In:Book of Abstracts:Fifth Annual Meeting of the Society of Magnetic Resonance in Medicine, Vol.1. Montreal, Quebec, Canada:SMRM; 1986:211.
  • 32) Iriguchi, N,; Iwasaki, A.; Yamamoto. T. et al. ln vivo 19F images obtained within minutes. In:Book of Abstracts:Fifth Annual Meeting of the Society of Magnetic Resonance in Medicine, Vol.4. Montreal, Quebec, Canada:SMRC:1986:1545.
  • 33) Hikida, K.; Iriguchi, N.; Yamamoto, T. et al. Localized MR utilizing a ferromagnetic cylinder. In:Program and Astracts:Fifth Annual Meeting ofthe Society for Magnetic Resonance Imaging, San Antonio Texas:SMRI; 1987:115.
  • 34) Yamai, S.; Iriguchi, N.; Yamamoto, T. et al. Phosphorus-31 real time spectroscopy. In:72nd Scientific Assembly and Annual Meeting of the Radiological Society of North America, Chicago:RSNA; 1986:341.
  • 35) Iriguchi, N.; Miyazaki, T.; Hasegawa, J. et al. F-19 MR imaging in vivo with FTPA. In:72nd Scientific Assembly and Annual Meeting of the Radiological Society of North America, Chicago:RSNA; 1986:315.
  • 36) Iwasaki, A.; Miyazaki. T.; Iriguchi, N. et al. Field inhomogeneity correction system using spectroscopic imaging by dephasing amplitude changing (SIDAC). In:72nd Scientific Assembly and Annual Meeting of the Radiological Society of North America, Chicago:RSNA; 1986:211.
  • 37) Miyazaki, T.; Yamamoto, T.; Iriguchi N. et al. Spectroscopic imaging by dephasing amplitude changing (SIDAC). In:72nd Scientific Assembly and Annual Meeting of the Radiological Society of North America, Chicago:RSNA; 1986:210.
  • 38) Hasegawa, J.; Iriguchi, N.; Ueshima. Y. et al. Natural abundance carbon-13 NMR imaging of the human arm. In:Program and Abstracts:Fifth Annual Meeting of the Society for Magnetic Resonance Imaging, San Antonio Texas:SMRI; 1987:46
  • 39) Young, S, W. Magnetic Resonance Imaging:Basic principles. New York:Raven Press; 1988:p.209.
  • 40) Iriguchi. N.; Iwasaki, A.; Yamamoto, T. et al. Whole body 2 tesla MRIS. Journal of NMR Medicine 6 (Suppl 2):196; 1986. [Japanese]
  • 41) Fujimoto. T.; Nakano, T.; Suemitsu, J. et al. Study of psychoses using 2 Tesla MR. Japanese Journal of Magnetic Resonance in Medicine 8 (Suppl 1):206; 1988. [Japanese]
  • 42) Fujii, M.; Uchida, T.; Fujimoto, T. et al. Study of dementia using 2 Tesla MR. Japanese Journal of Magnetic Resonance in Medicine 8 (Suppl 1):207; 1988. [Japanese]
  • 43) Uchimura, K,; Sasahira, M.; Fujimoto, T, et al. Human brain 31P-chemical shift imaging-Case study of cerebral infarction with wide lesions-. Japanese of Magnetic Resonance in Medicine 8 (Suppl 2):280; 1988. [Japanese]
  • 44) Sasahira, M.; Uchimura, M.; Fujimoto, T, et al. Phosphorous spectroscopic imaging of brain tumors. Japanese Journal of Magnetic Resonance in Medicine 8 (Suppl 2):281; 1988. [Japanese]
  • 45) Fujimoto, T.; Tsuji, T.:Nakano, T. et al. Study of schizophrenia and dementia using 31P spectroscopic imaging by dephasing amplitude changing. Japanese Journal of Magnetic Resonance in Medicine 8 (Suppl 2):279; 1988. [Japanese]
  • 46) Noguchi, S.; Nakano, T.; Fujimoto, T. et al. Study of muscle phoshorylase kinase deficiency using 31P-MRS and 31P-MRI. Japanese Journal of Magnetic Resonance in Medicine 8 (Suppl 2):217; 1988. [Japanese]
  • 47) Okada, A.; Utatsu, Y,; Fujimoto, T, et al. Study of myasthenia gravis using 31P-NMR spectrum. Japanese Journal of Magnetic Resonance in Medicine 8 (Suppl 1):121; 1988. [Japanese]
  • 48) Utatsu, Y.; Okada, A.; Fujimoto, T. et al. Study of muscle diseases using SIDAC (Spectroscopic imaging by dephasing amplitude changing) method. Japanese Journal of Magnetic Resonance in Medicine 8 (Suppl 2):201; 1988. [Japanese]
  • 49) Tsuji, T.; Fujimoto, T.; Simooki, S. et al. Effects of head muscle of canine to 31P spectra. Japanese Journal of Magnetic Resonance in Medicine 8 (Suppl 2):143; 1988. [Japanese]
  • 50) Shimooki, S.; Sakoda, H.; Fujimoto, T. et al. Evaluation of 31P SIDAC (Spectroscopic imaging by dephasing amplitude changing) method by phantom. Japanese Journal of Magnetic Resonance in Medicine 8 (Suppl 2):278; 1988. [Japanese]
  • 51) Fujimoto, T.; Noguchi, S.; Nakano, T. et al. Study of Alzheimer's disease using 2 tesla MR. Jpn. J. Med. Imaging 7:286; 1988. [Japanese]
  • 52) Noguchi, S.; Fujimoto, T.; Mitsuyama, Y. New technology for diagnosis of dementia:Study of usefulness of 31P-MRI Jpn. J. Med. Imaging 7:286; 1988. [Japanese]
  • 53) Okada, A.; Fujimoto, T. 1H-MR and 31P-MR spectroscopy. Image Technology & Information Display 20:78-81; 1988. [Japanese]
  • 54) Fujimoto, T.; Tsuji, T.; Nakano, T. et al. 1H imaging and 31P spectroscopic imaging in Alzheimer's disease. International Symposium MRI Update 93; 1988.
  • 55) Sasahira. M.; Uchimura, K.; Fujimoto, T. et al. Phosphorus spectroscopic imaging of human brain. International Symposium MRI Update 94; 1988.
  • 56) Fujimoto. T.; Noguchi, S.; Nakano, T. et al. MRS of Alzheimer's disease with presinile onset. In:Abstract of the 12th Japanese Society of CNS CT 116; 1989. [Japanese]
  • 57) Noguchi, S.; Fujimoto, T.; Mitsuyama, Y. et al. Study of usefulness of 31P-MRI for diagnosis of dementia; comparison with IMP-SPECT, In.:Abstract of the 12th Japanese Society of CNS CT 183; 1989. [Japanese]
  • 58) Sasahira, M.; Uchimura, K.; Fujimoto, T. et al. 31P spectroscopic imaging of brain tumors. Japanese Journal of Magnetic Resonance in Medicine 9 (Suppl 2):236; 1989. [Japanese]
  • 59) Sasahira, M.; Uchimura, K.; Fujimoto, T. et al. 31P spectroscopic imaging of brain tumors. In:Abstract of the 12th Japanese Society of CNS CT 191; 1989. [Japanese]
  • 60) Uchimura, K.; Sasahira, M.; Fujimoto, T. et al. 31P-chemical shift imaging of cerebral infarction and hemorrhage-Study of energy metabolism using SIDAC method. In:Abstract of the 12th Japanese Society of CNS CT 185; 1989. [Japanese]
  • 61) Okada, A.; Utatsu, Y.; Fujimoto, T, et al. 31P-MRS imaging of cerebral infarction-relation with SPECT and T1 relaxation time. In:Abstract of the 12th Japanese Society, CNS CT 184; 1989. [Japanese]
  • 62) Shimooki, S.; Nakano, T.; Fujimoto, T. et al. A quantitative study of chemical shift imaging by using phantom. Japanese Journal of Magnetic Resonance in Medicine 9 (Suppl 2):309; 1989. [Japanese]
  • 63) Noguchi, S.; Fujimoto, T. Application of 31P-magnetic resonance imaging to senile dementia of Alzheimer type. In:Book of Abstracts:Eighth Annual Meeting and Exhibition of the Society of Magnetic Resonance in Medicine, Vol.2. Amsterdam, The Netherlands:SMRM; 1989:669.
  • 64) Fujimoto, T.; Nakano, T.; Noguchi, S. et al. Study of dementia of Alzheimer type using 31P chemical shift imaging and 31P-NMR spectroscopy. Japanese Journal Psychiatric Treatment 4:1249-1257; 1989. [Japanese]
  • 65) Fujimoto, T.; Nakano, T.; Noguchi, S. et al. In-vivo 31P multivoxel spectroscopy in Alzheimer's disease. Progress in CT 11:435-441; 1989. [Japanese]
  • 66) Fujimoto, T.; Sasahira, M; Okada, A, et al. Clinical application of 31P chemical shift imaging and spectra. Innervision 4:33-38; 1989. [Japanese]
  • 67) Fujimoto, T.; Nakano, T.; Fujii, M. et al. 31P MRS of chronic schizophrenia. Japanese Journal of Magnetic Resonance in Medicine 10 (Suppl 1):249; 1990. [Japanese]
  • 68) Fujimoto, T.; Nakano, T.; Arimitsu, K. et al. Phosphorus-31 MR spectroscopy using 2 tesla MRS in epilepsy. Japanese Journal of Magnetic Resonance in Medicine 10 (Suppl 2):191; 1990, [Japanese]
  • 69) Fujii, M; Fujimoto, T.; Nakano, T. et al. Study of aging and 31P NMR spectra. Japanese Journal of Magnetic Resonance in Medicine 10 (Suppl 1):246; 1990, [Japanese]
  • 70) Sasahira, M.; Asakura, T.; Uchimura, K. et al. 31P chemical shift imaging of arteriovenous malformations. Japanese Journal of Magnetic Resonance in Medicine 10 (Suppl 1):199; 1990. [Japanese]
  • 71) Shimooki, S.; Fujimoto, T.; Nakano, T. et al. 31P spectrum studies on time course of change in brain metabolism after administration of phenobalbital to canines. Japanese Journal of Magnetic Resonance in Medicine 10 (Suppl 1:356; 1990. [Japanese]
  • 72) Fujimoto, T.; Nakano, T.; Sasahira, M. et al. MRS of brain disorders. Clinical Neuroscience 8:86-89; 1990. [Japanese]
  • 73) Sasahira, M; Uchimura, K.; Fujimoto, T, et al. 31P spectroscopic imaging of brain tumors. Progress in CT 12:59-66; 1990. [Japanese]
  • 74) Fujimoto, T.; Terada, K.; Shimohonji, M. et al. Future of MR spectroscopy. Image Technology & Information Display 22:81-84; 1990. [Japanese]
  • 76) Miyazaki, T. Automatic baseline correction for 31P-CSI Japanese Journal of Magnetic Resonance in Medicine 12:322-327; 1992. [Japanese]
  • 77) Fujimoto, T.; Nakano, T.; Noguchi, S. et al. Study of dementia of the Alzheimer type (presenile onset) using in vivo 31P MR chemical shift imaging. Japanese Journal of Magnetic Resonance in Medicine 11 (Suppl 1):192; 1991. [Japanese]
  • 78) Fujimoto, T.; Nakano, T.; Noguchi, S. et al. Study of epilepsy using 31P chemical shift imaging. Japanese Journal of Magnetic Resonance in Medicine 11 (Suppl 1):191; 1991. [Japanese]
  • 79) Nakamura, K.; Yatsushiro, K.; Asakura, T. et al. A study of epileptogenic foci on 31P-chemical shift imaging. Japanese Journal of Magnetic Resonance in Medicine 11 (Suppl 2):408; 1991. [Japanese]
  • 80) Fujimoto, T.; Nakano, T.; Noguchi, S. et al. Study of dementia, epilepsy and schizophrenia using 31P chemical shift imaging. Japanese Journal Magnetic Resonance in Medicine 11 (Suppl 2):248; 1991. [Japanese]
  • 81) Yatsushiro, K.; Kasamo, S.; Sasahira, M, et al. Evaluation by 31P chemical shift imaging of glioma before and after selective intraarterial chemotherapy and radiation therapy. Japanese Journal of Magnetic Resonance in Medicine 11 (Suppl 2):407; 1991. [Japanese]
  • 82) Terada, K.; Shimohonji, M,; Kawanishi, A. et al. Energy metabolism in brain tumor, cerebral infarction and intracerebral hemorrhage studied by 31P chemical shift imaging (CSI). Japanese Journal of Magnetic Resonance in Medicin 11 (Suppl 1):190; 1991. [Japanese]
  • 83) Sasahira, M.; Asakura, T.; Uchimura, K. et al. Clinical evaluation of cerebral infarction by 31P chemical shift imaging. Japanese Journal of Magnetic Resonance in Medicine 11 (Suppl 1):189; 1991. [Japanese]
  • 84) Fujimoto, T.; Nakano, T. Terada, K. et al. Study of dementia, epilepsy and shizophrenia using 31P-CSI. Japanese Journal of Clinical Medicine 49:233-237; 1991. [Japanese]
  • 85) Fujimoto, T.; Nakano, T.; Terada, K. et al. Study of phosphorous 31 MR spectroscopy of interictal epileptic patients using 2 Tesla MR. In:Book of Abstracts:Tenth Annual Scientific Meeting and Exhibition of the Society of Magnetic Resonance in Medicine, Vol.1 San Francisco, California, USA:SMRM; 1991:222.
  • 86) Utatsu, Y.; Izumi, K.; Fujimoto, T. et al. Localized proton MRS of the cerebellum in patients with spinocerebellar degeneration. Japanese Journal of Magnetic Resonance in Medicine 12 (Suppl 1):79; 1992. [Japanese]
  • 87) Fujimoto, T.; Nakano, T; Fujii, M. et al. Study of 31P-NMR spectra of chronic schizophrenia using 2T MRS. Japanese Journal of Magnetic Resonance in Medicine 12 (Suppl 1):80; 1992. [Japanese]
  • 88) Fujimoto, T.; Nakano, T.; Noguchi, S. et al. Study of dementia ofthe Alzheimer type (presenile onset) using in vivo 31P NMR chemical shift imaging. Jpn. J. Psychiatric Treatment 7:531-540; 1992. [Japanese]
  • 89) Fujimoto, T.; Nakano, T.; Takano, T. et al. Study of in vivo phosphorous 31 NMR spectra ofchronic schizophrenics. Japanese Journal of Clinical Psychiatry, 21:1471-1480; 1992. [Japanese]
  • 92) Collaborator of Jun Hasegawa. Works of Jun Hasegawa, 1996. [Japanese]

PART I BACKGROUND AND THEORETICAL BASIS

P.15 掲載の参考文献

  • 1) Ishii, T.;Kawabata, A.; Toyabe, T. Physics of Magnetic. Sogokagaku Publishing, 1980.[Japanese]
  • 2) Asanuma, M. World of N and S:Magnet. Tokai University Publishing, 1977. [Japanese]
  • 3) Tomonaga, S, Spin:The Period of Maturity of Quantum Mechanics. Cyuokoronsya, 1974. [Japanese]
  • 4) Segre, d. E. From X-rays to Quarks. Milano:Arnoldo Mondadori Editore, 1983.
  • 10) Gabillard, R. Mesure du temps de relaxation T2 en presence d'une inhomogeneite de champ magnetique superieure a la largeur de raie. C. R. Acad. Sci. Paris 232:1551-1553; 1951.
  • 21) Koenig, S. H.; Schillinger, W. E. Nuclear magnetic relaxation dispersion in protein solutions. J. Biol. Chem. 244:3283-3289; 1969.
  • 24) Frey, H. E.; Knispel, R. R.; Kruuv, J. et al. Brief communication:Proton spin-lattice relaxation studies of nonmalignant tissues of tumorous mice. J. Natl. Cancer Inst. 49:903-906; 1972.
  • 26) Hollis, D. P.; Saryan, L. A.; Morris, H. P. A nuclear magnetic resonance study of water in two morris hepatomas. Hopkins Med. J. 131:441-444; 1972.
  • 27) Damadian, R. V. Apparatus and method for detecting cancer in tissue, United States Patent 3789832; 1972.
  • 29) Abe Z. Measurement of information from the internal parts of objects due to application of nuclear magnetic resonance phenomenon. Public Official Gazett of Patent. 601-621; 1973. [Japanese]
  • 30) Lauterbur, P. C. Stable isotope distributions by NMR zeugmatography. Proc 1st international conference on stable isotopes in chemistry biolog and medicine. 255-260; 1973.
  • 31) Moon, R. B.; Richards, J. H. Determination of intracellular pH by 31P magnetic resonance. J. Biol. Chem. 248:7276-7278; 1973.
  • 37) Hutchison. J. M. S.; Mallard, J. R.; Goll, C. C. In-vivo imaging of body structures using proton resonance. In:Magnetic resonance and related phenomena, Proceedings of the 18th Ampere Congress, 9-14 September. Vol.1, P. S. Allen, E. R. Andrew, and C. A. Bates (Eds). Amsterdam:North-Holland, 1974:283-284.
  • 52) Damadian, R.; Goldsmith, M.; Minkoff, L. NMR in cancer:XVI. Fonar image of the live human body. Physiol. Chem. & Phys. 9:97-100; 1977.
  • 68) Smith, F. W. Whole body nuclear magnetic resonance imaging. Radiography XLVII:297-300; 1981.
  • 78) Escanye, J. M.; Canet, D.; Robert, J. Frequency dependence of water proton longitudinal nuclear magnetic relaxation times in mouse tissues at 20℃. Biochim. Biophys. Acta 721:305-311; 1982.
  • 80) Gadian, D, G. Nuclear Magnetic Resonance and its Applications to Living Systems. Oxford:Clarendon Press, 1982.
  • 83) Hilal, S. K.; Maudsley, A. A.; Simon, H. E. et al. In vivo NMR imaging of tissue sodium in the intact cat before and after acute cerebral stroke, AJNR Am J. Neuroradiol. 4:245-249; 1983.
  • 92) Bottomley, P. A. NMR:a new perspective on medicine. New York State Journal Medicine 84:438-440; 1984.
  • 104) Hasegawa, J.; Iriguchi, N.; Ueshima, Y. et al. Natural abundance carbon-13 NMR imaging of the human arm. In:Fifth Annual Meeting of the Society for Magnetic Resonance Imaging, San Antonio, Texas:SMRI; 1987:46.
  • 106) Miyazaki, T.; Yamamoto, T.; Iriguchi, N. et al. Spectroscopic imaging by dephasing amplitude changing (SIDAC). In:Book of Abstracts:Fifth Annual Meeting of the Society of Magnetic Resonance in Medicine, Montreal, Quebec, Canada:SMRM; 1986:856-857.

P.37 掲載の参考文献

  • 13) Yamamoto, T. Chemical shin imaging. Jpn. J. NMR. Med. 6:221-239; 1987. [Japanese]
  • 20) Naruse, S. Basics of MR Spectroscopy. In:Naruse, S., ed. Practice of Magnetic Resoncence Spectroscopy. Tokyo:Igakushoin; 1995:64. [Japanese]
  • 23) Miyazaki, T. Automatic baseline correction for 31P-CSI. Jpn. J. Magn. Reson. Med. 12:322-327; 1992. [Japanese]
  • 24) Gadian, D. G. Spectrometer design and operation. In:Nuclear magnetic resonance and its applications to living systems. New York:Oxford University Press; 1982:133-158.
  • 27) Yamamoto, T. Optimized design of an RF coil for magnetic resonance with quantitative analysis of a signal-to-noise ratio. Annu. Rep. College Med. Technol. Hokkaido Univ. 8:157-164; 1995. [Japanese]
  • 43) Manabe, A. Multi-angle projection shim (MAPshim) for localized volumes. In:Book proceedings:Third Scientific Meeting and Exhibition of the Society of Magnetic Resonance, Vol.2. Nice, France:SMR; 1995:696.
  • 45) Chen, W.; Adriany, G.; Zhu, X.-H. et al. Increase of creatine kinase rate in visual cortex of human brain during photic stimulation:an 31P NMR magnetization transfer study. In:Book of proceedings:Fourth Scientific Meeting and Exhibition of the International Society for Magnetic Resonance in Medicine, Vol.1. New York, USA:ISMRM; 1996:293.
  • 48) Nicklaus, D. J. Use of multiple receive coils for improved signal-to-noise in large field-of-view chemical shift imaging. In:Works in progress:Ninth Annual Scentific Meeting and Exhibition of the Society of Magnetic Resonance in Medicine, New York, USA:SMRM; 1990:1142.
  • 50) Tan, G.; Song, W.; Jesmanowicz, A. et al. Multichannel magnetic resonance spectroscopy. In:Book of proceedings:Twelfth Annual Scientific Meeting of the Society of Magnetic Resonance in Medicine, Vol 1. New York, USA:SMRM; 1993:370.

P.53 掲載の参考文献

  • 1) Lenkinski, R. E.; Schnall, M. D. MR spectroscopy and the biochemical basis of neurological disease. In:S. W. Atlas (Ed). Magnetic Resonance Imaging of the Brain and Spine, Second Edition. Philadelphia:Lippincott-Raven Publishers, 1996:pp. 1619-1653.
  • 3) Gadian, D. G. Nuclear Magnetic Resonance and its Applications to Living Systems. New York:Oxford University Press, 1982.
  • 4) Abraham, R. J.; Fisher,J.; Loftus, P. Introduction to NMR Spectroscopy. Chichester:John Wiley & Sons, 1988.
  • 5) Gunther, H. NMR Spectroscopy. Basic Principles, Concepts, and Applications in Chemistry, Second Edition. Chichester:John Wiley & Sons, 1992.
  • 6) Homans, S. W. A Dictionary of Concepts in NMR. Oxford:Clarendon Press, 1989.
  • 7) Sanders, J. K. M.; Hunter, B. K. Modern NMR Spectroscopy. A Guide for Chemists, Second Edition. Oxford:Oxford University Press, 1993.
  • 8) Laszlo, P. NMR of Newly Accessible Nuclei Volume 1. Chemical and Biochemical Applications. New York:Academic Press, 1983.
  • 9) Freeman, R. Double resonance. In:D. M. Grant, R. K. Harris (Eds). Encyclopedia of Nuclear Magnetic Resonance Volume 3. Chichester:John Wiley & Sons, 1996:pp. 1740-1749.
  • 10) Freeman, R. A Handbook of Nuclear Magnetic Resonance. Longman Scientific & Technical, 1988.
  • 11) Lamerichs, R. M. J. N. Luyten, P. R. Proton decoupling during in vivo whole body phosphorus MRS. In:D. M. Grant, R. K, Harris (Eds). Encyclopedia of Nuclear Magnetic Resonance Volume 6. Chichester:John Wiley & Sons, 1996:pp. 3825-3828.
  • 13) Kolem, H.; Miyazaki, T.; Schneider, M. et al. Nuclear Overhauser enhanced localized in vivo phosphorus spectroscopy using the CSI technique. In:Works in Progress:Ninth Annual Scientific Meeting and Exhibition of the Society of Magnetic Resonance in Medicine, New York, USA:SMRM; 1990; 1331.
  • 16) Akitt. J. W. NMR and Chemistry. An introduction to modern NMR spectroscopy. Third Edition. London:Chapman & Hall, 1992.
  • 25) Leach, M.; Le Moyec, L.; Podo, F. Chapter 18, MRS of tumours:Basic Principles. In:J. D. De Certaines, W. M. M. J. Bovee, F. Podo (Eds). Magnetic Resonance Spectroscopy in Biology and Medicine. Oxford:Pergamon Press, 1992:pp. 295-344.
  • 26) Pettegrew, J. W.; Minshew, N. J. Chapter 12, Molecular insights into schizophrenia In:N. C. Andreasen (Ed). Schizophrenia:From Mind to Molecule. Washington, DC:American Psychiatric Press, 1994:pp. 221, 226-228.
  • 33) Stryer, L. Biochemistry. Fourth Edition. New York:W. H. Freeman and Company, 1995.
  • 35) Agranoff, B. E. Chapter 5, Lipids. In:G. J. Siegel, B. W. Agranoff, R. W. Albers, P. B. Molinoff (Eds). Basic Neurochemistry:Molecular, Cellular, and Medical Aspects, Fourth Edition, New York:Raven Press, 1989:pp. 91-107.
  • 37) Voet. D.; Voet, J. G. Biochemistry. Second Edition. New York:John Wiley & Sons, 1995.
  • 38) Horton, H. R.; Moran, L. A.; Ochs, R. S. et al. Principles of Biochemistry. Second Edition, Prentice Hall, 1996.
  • 39) Chance, B.; Leigh Jr. J. S.; McLaughlin, A. C. et al. Phosphorus-31 spectroscopy and imaging, In:C. L. Partain, R. R. Price, J. A. Patton, M. V. Kulkarni, A. E. James (Eds). Magnetic Resonance Imaging. Vol. 2. Philadelphia:W. B. Saunders Company, 1988:pp. 1501-1520.
  • 45) Huppi, P. S,:Posse. S.; Lazeyras, F. et al. Brain development in preterm and term babies studied with 1H-magnetic resonance spectroscopy using short-echo time STEAM technique. In:Book of Abstracts:Tenth Annual Scientific Meeting and Exhibition of the Society of Magnetic Resonance in Medicine, Vol.1. San Francisco, California USA 1991:377,
  • 51) Hanicke, W.;Michaelis, T.;Merboldt, K. D. et al. On the use of a fully automated data analysis method for in vivo MRS. Metabolite concentrations and relaxation times from proton spectra of human brain. In:Proceedings:Twelfth Annual Scientific Meeting of the Society of Magnetic Resonance in Medicine, Vol.2 New York, USA:SMRM; 1993:977,
  • 56) Dezortova, M.; Hajek, M.; Hejcmanova, L. The changes of N-acetylaspartate and creatine/Phosphocreatine concentrations in patients with phenylketonuria. In:Proceedings:Third Scientific Meeting and Exhibition of the Society of Magnetic Resonance, Vol.3. Nice, France:1995:1833.
  • 57) Pouwels, P. J. W.;Hanicke, W.;Frahm, J. On a concentration gradient of cerebral metabolites in human gray matter as determined by quantitative localized proton MRS. In:Proceedings:Third Scientific Meeting and Exhibition of the Society of Magnetic Resonance, Vol.3. Nice, Fance:SMR; 1995:1957.
  • 58) Saunders, D. E.; Howe, F. A.;van den Boogaart, A. et al. Ageing of the human adult brain:In vivo quantitation of metabolite content with proton magnetic resonance spectroscopy. In:Proceedings:Third Scietific Meetings and Exhibition of the Society of Magnetic Resonance, Vol.3. Nice, France:SMR; 1995:1804.
  • 59) Hajek M. Quantitative NMR spectroscopy. Comments on methodology of in vivo MR spectroscopy in medicine. Quart. Magn. Res. in Biol. Med.2:165-193; 1995.
  • 63) Tallan, H. H.; Moore, S.; Stein, W.H. N-acetyl-L-aspartic acid in brain. J. Biol. Chem. 219:257-264; 1956,
  • 67) Miyake, M.; Kakimoto. Y.; Sorimachi. M. A gas chromatographic method tbr the determination of N acetyl-L-aspartic acid, N-acetyl-α-aspartylglutamic acid and β-citryl-L-glutamic acid and their distributions in the brain and other organs of various species of animals. J. Neusochem. 36:804-810; 1981,
  • 68) Tallan, H. H. Studies on the distribution of N-acetyl-L-aspartic acid in brain. J. Biol Chem. 224:41-45; 1957.
  • 71) Goldstein. F. B. Biosynthesis of N-acetyl-L-aspartic acid. J. Biol. Chem. 234:2702-2706; 1959.
  • 73) Slusher, B. S.;Robinson, M. B.;Tsai, G. et al. Rat brain N-acetylated α-linked acidic dipeptidase activity:Purification and immunologic characterization. J. Biol Chem. 265:21297-21301; 1990,
  • 91) Mcllwain, H.;Bachelard, H. S. Biochemistry and the Central Nervous System. Fifth Edition. Edinburgh:Churchill Livingstone, 1985:pp. 296-297.
  • 102) Miyake, M.; Morino, H.; Mizobuchi, M. et al. N-acetyl-L-aspartic acid, N-acetyt-α-L-aspartyl-L-glutamic acid and β-citryl-L-glutamic acid in Human urine. Clinica. Chimica. Acta 120:119-126; 1982.
  • 124) Rothman, D, L.; Petroff, O. A. C.;Behar, K. L. et al. Localized 1H NMR measurements of γ-aminobutyric acid in human brain in vivo. Proc. Natl. Acad. Sci. USA 90:5662-5666; 1993.
  • 125) McGeer, P, L.; McGeer. E. G. Chapter 15. Amino acid neurotransnmitters. In:G. J. Siegel, B. W. Agranoff, R. W, Albers. P. B. Molinoff (Eds). Basic Neurochemistry:Molecular, Cellular, and Medical Aspects, Fourth Edition. New York:Raven Press, 1989:pp. 311-332.
  • 126) Casey. D. E.;Gerlach, J.; Magelund. G. et al. γ-Acetylenic GABA in tardive dyskinesia. Arch. Gen. Psychiatry 37:1376-1379; 1980.
  • 127) Perry, T. L.; Kish, S. J.; Buchanan. J. et alγ-aminobutyric-acid deficiency in brain of schizophrenic patients. Lancet 3:237-239:1979.
  • 129) Petroff. O. A. C.; Rothman, D. L.; Behar, K. L. et al. Initial observations on effect of vigabatrin on in vivo 1H spectroscopic measurements of γ-aminobutyric acid, glutamate. and glutamine in human brain. Epilepsia 36:457-464; 1995.

PART II CLINICAL APPLICATIONS

P.92 掲載の参考文献

  • 2) Asakura, T.; Sasahira, M. Magnetic resonance spectroscopy and chemical shift imaging of the brain. Neurosiences 20:83-101:1994.
  • 7) Sasahira, M.; Asakura, T.; Uchimura, K. et al. 31P chemical shift imaging of brain tumors and cerebrovascular disease. Progress in CI 14:517-531; 1992, [Japanese]
  • 12) Arnold, D. L.;Shoubridge, E. A.; Feindel, W. et al. Metabolic changes in cerebral gliomas within hours of treatment with intra-arterial BCNU demonstrated by phosphorus magnetic resonance spectroscopy. Can. J. Neurol. Sci. 14:570-575; 1987,

P.157 掲載の参考文献

  • 4) Uchimura, K. A clinical study on the energy metabolism and intracellular pH in human brain with cerebral infarction; Detection by 31P-magnetic resonance spectroscopy. Med. J. Kagoshima Univ. 42:223-244; 1990.
  • 9) Asakura, T.; Sasahira, M. Magnetic resonance spectroscopy and chemical shift imaging of the brain. Neurosciences 20:83-101; 1994.
  • 10) Terada, K.; Moriya, N.; Fujimoto, T. et al. 31P chemical shift imaging in cerebral ischemic disorders. Abstracts of 51st Annual Meeting of the Japan Neurosurgical Society. Book 2. Kagoshima p. 198;1992.

P.185 掲載の参考文献

  • 1) Sasahira, M.;Uchimura, K.;Nagayama, T. et al. Evaluation of cerebral blood flow and cerebral phosphorus metabolism in arteriovenous malformations by 123I IMP SPECT and 31P chemical shift imaging. Progress in CT 12:641-649; 1990. [Japanese]
  • 2) Terada, K.; Moriya, N.; Fujimoto, T. et al. 31P chemical shift imaging in cerebral ischemic disorders. Abstracts of 51st Annual Meeting of the Japan Neurosurgical Society. Book 2. Kagoshima p. 198;1992.

P.197 掲載の参考文献

  • 1) Asakura, T.; Sasahira, M. Magnetic resonance spectroscopy and chemical shift imaging of the brain. Neurosciences 20:83-101; 1994.
  • 2) Uchimura, K.; Asakura, T.; Sasahira, M.;Terada, K. et al. Magnetic resonance spectroscopy (MRS) and chemical shift imaging (CSI) studies on cerebral metabolism in cerebrovascular disease. Nippon Rinsho 51 (suppl):132-139; 1993. [Japanese]

P.228 掲載の参考文献

  • 3) Miatto, O.:Gonzalez, G.; Buonanno. F. S. et al. 31-Phosphorus nuclear magnetic resonance studies in dementia. Neurology 36 (Suppl 1):105;1986.
  • 9) Bueri. J. A.; Gorell. J. M.; Levine, S. R. et al. Cerebral phosphate metabolism in Alzheimer and Parkinson dementia measured by 31P NMR spectroscopy. Neurology 37 (Suppl.1):160:1987.
  • 10) Fujimoto, T.:Nakano. T.; Noguchi. S. et al. In-vivo 31P multivoxel spectroscopy in Alzheimer's disease. Progress in CT 11:435-4411 1989. [Japanese]
  • 11) Fujimoto, T.; Nakano, T.; Noguchi, S, et al. Study of dementia of Alzheimer type using 31P chemical shift imaging and 31P-NMR spectroscopy. Japanese Journal of Psychiatric Treatment 4:1249-1257; 1989. [Japanese]
  • 12) Fujimoto, T.:Noguchi, S.:Nakano, T. et al. ln vivo phosphorous-31 NMR spectroscopy in Alzheimer's disease. ln:T. Nagatsu. A, Fisher, M. Yoshida (Eds). Basic. Clinical, and Therapeutic Aspects of Alzheimer's and Parkinson's Diseases Volume 2. Advances in Behavioral Biology Volume 38B, New York:Plenum Press, 1990:pp. 67-72.
  • 13) Fujimoto, T.:Nakano. T.:Noguchi, S, et al. Study of dementia of the Alzheimer type (presenile onset) using in vivo 31P NMR chemical shift imaging. Japanese Journal of Psychiatric Treatment 7:531-540; 1992. [Japanese]
  • 16) Bluml, S.; Danielsen, E. R.; Ross, B, D. Proton decoupled 31P MRS in Alzheimer disease. In:Proceedings:Fourth Scientific Meeting and Exhibition of the International Society for Magnetic Resonance in Medicine, Vol.1. New York, USA:ISMRM:1996:304.
  • 17) Sappey-Marinier, D.; Bonmartin, A. Angelie, E. et al. 1H MRSI and 31P MRS did not detect any metabolic difference between Alzheimer's disease and normal aging. In:Proceedings:Third Scientific Meeting and Exhibition of the Society of Magnetic Resonance, Vol. 3. Nice, France:SMR; 1995:1811.
  • 18) Bonmartin, A.:Sappey-Marinier, D.:Barbier. E. et al. Comparative morphometric and metabolic study between Alzheimer's disease and normal aging using 3D-MRI and 31P MRS. In:Proceedings:Fourth Scientific Meeting and Exhibition of the International Society for Magnetic Resonance in Medicine, Vol.2. New York, USA:ISMRM; 1996:927,
  • 19) Fujimoto. T,; Matsumoto, T.; Takano. T. et al. Changes of 31P spectra in hippocampal regions in patients with Alzheimer disease due to the progress of the disease. In:Proceedings:Fifth Scientific Meeting and Exhibition of the International Society for Magnetic Resonance in Medicine, Vol.2. Vancouver, Canada:ISMRM; 1997:1180.
  • 22) Renshaw, P. F.:Satlin, A.; Johnson, K. A, Parietal lobe proton MRS in patients with Alzheimer's disease. In:Proceeedings:Twelfth Annual Scientific Meeting of the Society of Magnetic Resonance in Medicine, Vol.1. New York, USA:SMRM; 1993:232,
  • 23) Frederick. B, de B.:Satlin. A. Yurgelun-Todd. D. et al. In vivo proton MRS of Alzheimer's disease in the parietal and temporal lobes. In:Poceedings:third Scientific Meeting and Exhibition of the Society of Magnetic Resonance, Vol.3. Nice, France:SMR; 1995:1810,
  • 28) Block, W.; Traber, F.;Horn, R, et al. Metabolic changes detected by 1H-MR-spectroscopic imaging of the hippocampus in patients with Alzheimer's disease. Proceedings:Third Scientific Meeting and Exhibition of the Society of Magnetic Resonance, Vol.3. Nice, France:SMR; 1995:1813,
  • 29) Schuff, N.; Knowlton, R.; Amend. D, L et al. Changes of NAA in Alzheimer's disease are more prominent in hippocampus than in cortical gray matter:A 1H MR spectroscopic imaging study. In:Proceedings:Fourth Scientific Meeting and Exhibition of the International Society for Magnetic Resonance in Medicine, Vol.1. New York, USA:ISMRM; 1996:308.
  • 32) Sappey-Marinier. D.:Angelie, E;Meltz, P. et al. Brain metabolic changes during normal aging detected by proton MR spectroscopic imaging. In:Proceedings:Fourth Scientific Meeting and Exhibition of the International Society for Magnetic Resonance in Medicine, Vol. 2. New York, USA:ISMRM; 1996; 926.
  • 33) Mohanakrishnan, P.:Vonsattel. J, P,;Husain. M. M. et al, Regional metabolic changes in Alzheimer's disease using high resolution proton NMR. In:Proceedings:Third Scientific Meeting and Exhibition of the Society of Magnetic Resonance, Vol. 3. Nice, France:SMR; 1995:1815,
  • 34) Fujimoto, T.:Noguchi, S.; Tsuji, T. et al. Study of dementia in the elderly using magnetic resonance (MR). Part II.-Application of high field MRI. Japanese Journal of Psychiatric treatment 3:909-917; 1988. [Japanese]
  • 37) Smith, C. D.; Gallenstein III, L. G.; Markesbery, W. R. 31P spectroscopy in Alzheimer's and Pick's disease using post-mortem perchloric acid brain extracts. In:book of Abstracts:Seventh Annual Meeting and Exhibition of the Society of Magnetic Resonance in Medicine, Vol.1. San Francisco, California USA:SMRM; 1988:444.
  • 38) Lishman. W, A, Organic Psychiatry. The Psychological Consequences of Cerebral Disorder, Second Edition. Oxford:Blackwell Scientific Publications,1987:pp. 392-393,
  • 42) MacKay, S.; Meyerhoff, D. J.:Constans,J. M. et al. Effects of subcortical ischemic vascular dementia on cerebral 1H metabolites. In:Proceedings:Second Meeting of the Society of Magnetic Resonance, Vol.2. San Francisco, California USA:SMR; 1994:597,
  • 44) Brooks. W. M.; Wesley, M. H.:Kodituwakku, P. et al. 1H-MRS in Binswanger's disease and leukoence-phalopathy of normal aging. In:Proceedings:Third Scientific Meeting and Exhibition of the Society of Magnetic Resonance, Vol.1. Nice, France:SMR; 1995:386.

P.256 掲載の参考文献

  • 1) Mooyaart, E, L;Kamman, R. L.; Minderhoud, J. M, et al. 31P NMR spectroscopy in patients with multiple sclerosis (MS):A correlalion with clinical data. In:Book of Abstracts:Eighth Annual Meeting and Exhibition of the Society of Magnetic Resonance in Medicine, Vol.1. Amsterdam, the Netherlands:SMRM; 1989:456.
  • 3) Arnold. D. L.:Matthews, P. M.; Francis. G, et al. Proton MR spectroscopy in the evaluation multiple sclerosis in human in vivo:Assessment of the load of disease. In:Book of Abstracts:Eighth Annual meeting and exhibition of the Society of Magnetic Resonance in Medicine,Vol.1. Amsterdam, The Netherlands; SMRM; 1989:455.
  • 7) Grossman, R.I.; Lenkinski, R. E;Ramer, K. N. et al. MR proton spectroscopy in multiple sclerosis. AJNR Am. J. Neuroradiol. 13:1535-1543:1992.
  • 10) Constans, J. M.; Fernandez, J.:Viader. F. et al. Automated single voxel 1H MR spectroscopy in multiple sclerosis:Study of normal appearing white matter and study of differently aged lesions. In:Proceedings:Fourth Scientific Meeting and Exhibition of the International Society for Magnetic resonance in Medicine, Vol.2. New York, USA:ISMRM; 1996:943,
  • 11) Narayana, P. A.:Wolinsky. J. S.; Fenstermacher, M. J. Proton magnetic resonance spectroscopy in multiple sclerosis. In:Book of Abstracts:Eighth Annual Meeting and Exhibition of the Society of Magnetic Resonance in Medicine, Vol.1. Amsterdam, The Netherlands:SMRM; 1989:457.
  • 15) Confort-Gouny, S.; Vion-Dury, J.;Chabrol B. et al. Localized proton MR spectroscopy in X-linked adrenoleukodystrophy. In:Proceedings:Twelfth Annual Scientific Meeting of the Society of Magnetic Resonance in Medicine, Vol.3. New York, USA:SMRM; 1993:1565.
  • 24) Davie, C, A.:Barker. G. J.:Davies, S. E. C. et al. Proton magnetic resonance spectroscopy in Huntington's disease. In:Proceedings:Second Meeting of the Society of Magnetic Resonance, Vol.2. San Francisco, USA:SMR; 1994:577.
  • 25) Taylor-Robinson, S. D.; Weeks, R. A,; Marcus, C. et al. 1H MR spectroscopy demonstrated an increased Glx peak in the striatum of patients with Huntington's disease. In:Proceedings:Second Meeting of the Society of Magnetic Resonance, Vol.2. San Francisco, USA:SMR; 1994:578.

P.268 掲載の参考文献

  • 4) Kuzniecky, R. L; Jackson, G. D. Magnetic resonance in epilepsy. New York:Raven Press, 1995,
  • 5) Fujimoto. T.:Asakura. T.; Nakamura, K. Epilepsy and MRS. In:H. Akimoto, T. Yamauchi (Eds). Advances in Epileptology No.3. lwasaki Gakujutu Shuppansha, 1996:pp. 327-357. [Japanese]
  • 6) Niiro. M.; Asakura, T,:Nakamura. K. et al. 31P chemical shift imaging of epileptic brains. Progress in CT 12:493. 503; 1990. [Japanese]
  • 7) Nakamura, K.; Yatsushiro. K,:Asakura. T. et al. A study of epileptic brains with 31P-Chemical shift imaging. Neurosciences 18 (Suppl.) 159-162; 1992. [Japanese]
  • 9) Fujimoto, T.; Nakamura. K.:Haruzono, A, et al. Changes in 31phosphorus metabolism in localization-related epilepsies. Epilepsia 36 (Suppl.3):S 146; 1995.
  • 13) Chu, W-J.;Hetherington, H. P.:Kuzniecky, R.I. et al. Is the intracellular pH different from normal in the epileptic focus of epilepsy patients? In:Proceedings:Third Scientific Meeting and Exhibition of the Society of Magnetic Resonance, Vol.1. Nice, France:SMR; 1995:142.
  • 14) Chu, W.-J.:Hetherington. H.P.:Vaughan, J. T:et al. High resolution in vivo 31P spectroscopy of temporal lobe epilepsy on 4.1 test whole body NMR. In:Proceedings:Fourth Scientific meeting and Exhibition of the International Society for Magnetic Resonance in Medicine, Vol.1. New York, USA:ISMRM; 1996:133.
  • 16) Asakura, T.; Nakamura, K.; Terada, K. et al. New method of presurgical evaluation of epilepsy surgery with 31P-chemical shift imaging. Epilepsia 34 (Suppl.2):169; 1993,
  • 18) Fujimoto, T.;Matsumoto, T.; Haruzono, A. et al. Study of temporal lobe epilepsy using 1H and 31PMRS. In:Proceedings:Fourth Scientific Meeting and Exhibition of the International Society for Magnetic Resonance in Medicine, Vol.2. New York, USA:ISMRM; 1996:959.
  • 24) Breiter, S, N,; Arroyo, S.; Mathews, V. P, et al. Proton MR spectroscopy in patients with seizure disorders. AJNR Am. J. Neuroradiol.15:373-384:1994,
  • 31) Ende, G.:Knowlton, R.;Laxer, K. D, et al. NAA is a more sensitive marker of hippocampal disease than atrophy:Evidence that NAA is a neuronal marker. In:Proceedings:Fourth Scientific Meeting and exhibition of the International Society for Magnetic Resonance in Medicine, Vol.1. New York, USA:ISMRM; 1996:137,
  • 32) Laxer, K. D.;Ende. G.:Walker, J. A. et al. NAA as ameasure of hippocampal function in temporal lobe epilepsy. In:Proceedings:Fourth Scientific Meeting and Exhibition of the International Society for Magnetic Resonance in Medicine, Vol.1. New York, USA:ISMRM; 1996:136.
  • 33) Ende, G:Laxer, K, D.;Knowlton, R, et al Quantitative 1H SI shows bilateral metabolite changes in unilateral TLE patients with and without hippocampal atrophy. In:Proceedings:third Scientific Meeting and Exhibition of the Society of Magnetic Resonance, Vol.1. Nice, France:SMR; 1995:144.
  • 35) Hugg, J. W.; Hetherington, H, P.; Butterworth, E. J. et al. High resolution 1H MRSI at 4.1T localizes temporal lobe epilepsy and detects recovery after surgery. In:Proceedings:Fourth Scientific Meeting and Exhibition of the International Society for Magnetic Resonance in Medicine, Vol.1. New York,USA:ISMRM 1996:134.
  • 36) Fujimoto. T.; Yamada, K.; Nakano. T. et al. Proton magnetic resonance spectroscopy in patients with epileptic psychotic syndrome. Jap. J. Psych. Neurol.48:360-363; 1994.
  • 37) Fujimoto, T.; Yamada, K,;Nakano, T. et al. Proton spectroscopy using MRS with 2T in patients with epileptic psychoses. In:Proceedings:Twelfth Annual Scientific Meeting of the Society of Magnetic Resonance in Medicine, Vol.3. New York, USA:SMRM; 1993:1541.
  • 38) Maier, M.; Mellers, J.; Ron, M. A. et al. Association between hippocampal NAA and psychosis:1H MRS study of schizophrenia and epilepsy. In:Proceedings:Third Scientific Meeting and Exhibition of the Society of Magnetic Resonance, Vol.1. Nice, France:SMR; 1995:143.
  • 39) Petroff, O. A. C; Rothman, D. L.;Behar, K. L, et al. Gabapentin increases brain GABA levels in patients with epilepsy. In:Proceedings.:Third Scientific Meeting and Exhibition of the Society of Magnetic Resonance, Vol.1. Nice, France:SMR; 1995:140.
  • 40) Petroff,O. A. C.; Rothman, D. L; Behar, K. L. et al. Initial observations on effect of vigabatrin on in vivo 1H spectroscopic measurements of γ-aminobutyric acid, glutamate, and glutamine in human brain. Epilepsia 36:457-464;1995.41) Petroff,O. A. C.; Rothman, D. L;Behar, K. L. et al. Low brain GABA is associated with poor seizure control in patients with complex partial epilepsy, In:Proceedings:Fourth Scientific Meeting and Exhibition of the International Society for Magnetic Resonance in Medicine, Vol.1. New York, USA:ISMRM; 1996:131,
  • 42) Petroff, O. A. C.; Rothman. D. L;Behar, K. L. et al. Estimates of the rate of GABA synthesis in patients with epilepsy. In:Proceedings:Fourth Scientific Meeting and Exhibition of hte International Society for Magnetic Resonance in Medicine, Vol.2. New York, USA:ISMRM; 1996:962.
  • 43) Rothman, D. L; Behar, K, L; Mattson. R. H. et al. Homocarnosine levels are elevated in epileptic patients taking vigabatrin:a novel measure of cortical pH. In:Proceedings:Fourth Scientific Meeting and Exhibition of hte International Society for Magnetic Resonance in Medicine, Vol.1. New York, USA:ISMRM; 1996:130,
  • 45) Savic, I;Ke, Y.; Thomas, M. A. et al. Localized 1H MR spectroscopy in partial epilepsy. In:Proceedings:Fourth Scientific Meeting and Exhibition of the International Society for Magnetic Resonance in Medicine, Vol.2. New York, USA:ISMRM; 1996:956.
  • 46) Novotny, E. J,;Rothman, D. L. Altered amino acid levels in pediatric epilepsies. In:Proceedings:Fourth Scientific Meeting and Exhibition of the International Society for Magnetic Resonance in Medicine, Vol.1. New York, USA:ISMRM; 1996:132.

P.298 掲載の参考文献

  • 1) Fujimoto. T.; Nakano, T.;Terada, K. et al. Study of dementia, epilepsy and shizophrenia using 31P-CSI. Japanes Journal of Clinical Medicine 49:233-237;1991. [Japanese]
  • 2) Nasrallah, H. A.;Pettegrew, J. W. In:NMR Spectroscopy in Psychiatric Brain Disorders, Washington, DC:American Psychiatric Press, lnc. 1995.
  • 4) Pettegrew, J. W:Panchalingam, K.;Keshevan. M. et al. Alterations in membrane phospholipid and high energy phosphate metabolism in the dorsal prefrontal cortex of schizophrenics. In:Book of Abstracts:Eighth Annual Meeting and Exhibition of the Society of Magnetic Resonance in Medicine, Vol. 1. Amsterdam, The Netherlands:SMRM:1989:463.
  • 6) Pettegrew, J. W.;Minshew, N. J. Chapter 12. Molecular insights into schizophrenia. In:N. C. Andreasen (Ed), Schizophrenia:From Mind to Molecule. Washington. DC:American Psychiatric Press, Inc. 1994:pp. 221-243.
  • 7) Fujimoto. T.; Nakano, T.;Takano, T. et al. Study of in vivo phosphorus 31NMR spectra of chronic schizophrenics. Japanes Journal of Clinical Psychiatry 21:1471-1480:1992, [Japanese]
  • 11) Williamson, P. C.;Drost, D. J. Stanley, J. A, et al. 31P-MRS in the study of schizophrenia. In:H. A. Nasral-lah, J. W, Pettegrew (Eds). NMR Spectroscopy in Psychiatric Brain Disorders, Washington, DC:American Psychiatric Press, Inc. 1995:pp. 107-129.
  • 13) Kato, T,:Shioiri, T.:Murashita, J, et al. Phase-encoded 31P-MRS of the frontal lobes in patients with schizophrenia. In:Poceedings:Second Meeting of the Society of Magnetic Resonance, VoL 2. San Francisco, California USA:SMR;1994:602.
  • 14) Deicken, R. F. Chapter 4, 31P-MRS of the human brain in the study of schizophrenia. ln:H. A. Nasrallah, J. W. Pettegrew (Eds). NMR Spectroscopy in Psychiatric Brain Disorders. Washington, DC:American Psychiatric Press. Inc. 1995:pp. 79-106,
  • 17) Arias-Mendoza, F.;Elkashef, A.;Stoyanova, R. et al, Coenzyme Q1o effect on cognitive functions and bioenergetics in schizophrenia:an anatomically localized 31p magnetic resonance study, In:Proceedings:Fourth Scientific Meeting and Exhibition of the International Society for Magnetic Resonance in Medicine, Vol.2. New York, USA:ISMRM; 1996:1003. 18) Dogomori, H.;Fujimoto, T.; Nakano, T, et al. Study of in vivo phoshorus 31 NMR spectra of neuroleptic malignant syndrome. Japanese Journal of Clinical Psychiatry 23:1067-1076; 1994. [japanese]
  • 20) Potwarka, J.; Drost. D. J.:Williamson. P. C. A study of schizophrenia using 2D 31P chemical shift imaging with 1H decoupling. In:Proceedings; Fourth Scientific Meeting and Exhibition of the International Society for Magnetic Resonance in Medicine, VoL 2. New York, USA:ISMRM; 1996:998.
  • 21) Moore, C M.;Redmond, O. M,;Buckley, P. et al. In vivo proton NMR spectroscopy (STEAM) in patients with schizophrenia, In:Book in Abstract:Eleventh Annual Scientific Meeting of the Society of Magnetic Resonance in Medicine, Vol.1. Berlin, Germany:SMRM; 1992:1933.
  • 23) Yurgelun-Todd. D, A.; Moore, C. M.; Bonello, C. M et al. NAA/Cr ratio correlates inversely with gray matter in the left temporal lobe of schizophrenic patients. In:Proceedings.:Fourth Scientific Meeting and Exhibition of the International Society for Magnetic Resonance in Medicine, Vol.2. New York, USA:ISMRM; 1996:999,
  • 25) Nasraltah, HE A.;Skinner, T. E.;Schmalbrock, P. et al. Chapter 1, In vivo 1H-NMR Spectroscopy of the limbic temporal lobe in patients with schizophrenia. In:H. A. Nasrallah, J. W. Pettegrew (Eds), NMR Spectroscopy in Psychiatric Brain Disorders. Washington, DC:American Psychiatric Press., lnc. 1995:PP. 1-20.
  • 27) Komoroski, R. A.:Heimberg, C.;Lawson. W. et al. A localized, in vivo 1H NMR spectroscopy study of schizophrenics. In:Proceedings:Third Scientific Meeting and Exhibition of the Society of Magnetic Resonance, Vol.3. Nice, France:SMR; 1995:1846.
  • 30) Bertolino, A.; Nawroz, S.; Mattay. V. S, et al. A specific anatomical pattern of neuronal impairment in schizophrenia as assessed by multislice 1H-MRSI. In:Proceedings:Third Scientific Meeting and Exhibition of the Society of Magnetic Resonance, Vol.3. Nice, France. SMR; 1995:1844,
  • 32) Choe, B.-Y.; Kim, K.-T.:Suh. T,-S, et al. Alterations of proton metabolites in drug-naive, chronic schizophrenia by MRS. In:Proceeding:Second Meeting of the Society of Magnetic Resonance, Vol.2. San Francisco, California USA:SMR; 1994:603.
  • 33) Bertolino. A.;Callicott, J. H.;Elman,I. et al. Proton magnetic resonance spectroscopic imaging in drug naive patients with schizophrenia:Regionality of neuronal damage. In:Proceedings:Fourth Scientific Meeting and Exhibition of the International Society for Magnetic Resonance in Medicine, Vol. 2. New York, USA:ISMRM; 1996:1002.
  • 34) Paul, C, R.; Lenkinski. R, E; Boyko, O. B. et al. Proton magnetic resonance spectroscopy of patients with first episode of schizophrenia. In:Proceedings:Fourth Scientific Meeting and Exhibition of the International Society for Magnetic Resonance in Medicine, Vol.2. New York, USA:ISRM; 1996:1001,
  • 36) Thomas, M, A.;Ke, Y,; Caplan, R. et al. Frontal lobe 1H MR spectroscopy of children with schizophrenia.In:Proceedings:Fourth Scientific Meeting and Exhibition of the International Society for Magnetic Resonance in Medicine, Vol.2. New York, USA:ISMRM; 1996:1000,
  • 37) Choe, B,-Y.; Suh, T.-S.; Shinn, K.-S, et al. Correlation between clinical evaluations and metabolic changes in chronic schizophrenia after neuroleptic treatment by in vivo 1H MRS. In:Proceedings:Fourth Scientific Meeting and Exhibition of the International Society for Magnetic Resonance in Medicine, Vol.2. New York, USA:ISMRM; 1996:1004.
  • 38) Choe, B.-Y.:Suh. T,-S.:Shinn, K.-S. et al, Evaluation of neuroleptic treatment in chronic schizophrenia by 1H MRS. In:Proceeding:Second Meeting of the Society of Magnetic Resonance, Vol.2. San Francisco, California USA:SMR; 1994:604.
  • 39) Komoroski, R. A.:Omori. M.;Pearce. J. et al. An in vitro 1H NMR study of post-mortem brains of schizophrenics. In:Proceedings:Third Scientific Meeting and Exhibition of the Society of Magnetic Resonance, Vol.3. Nice, France:SMR:1995:1845.
  • 40) Fujimoto, T.;Matsumoto. T.;Uchida, T. et al:31P chemical shift imaging in bipolar disorder. In:Proceedings:Fifth Scientific Meeting and Exhibition of the International Society for Magnetic Resonance in Medicine, Vol.2. Vancouver, B.C., Canada:ISMRM; 1997:1168,
  • 41) Moore, C. M,; Christensen, J. D.; Lafer, B. et al. Decreased adenosine triphosphate in the basal ganglia of depressed subjects:A phosphorus-31 magnetic resonance spectroscopy study. In:Proceedings:Fourth Scientific Meeting and Exhibition of the International Society for Magnetic Resonance in Medicine, Vol. 2. New York, USA:ISMRM; 1996:996.
  • 42) Christensen, J. D.;Renshaw, P. F.; Stoll. A. L. et al. 31p spectroscopy of the basal ganglia in major depression. In:Proceeding:Second Meeting of the Society of Magnetic Resonance, Vol.2. San Francisco, California USA:SMR; 1994:608.
  • 43) Kato, T.;Shioiri, T.;Murashita, J. et al. Cerebral asymmetry of high energy phosphate metabolism in manic-depressive illness measured with 31P one dimensional chemical shift imaging. In:Proceeding:Twelfth Annual Scientific Meeting of the Society of Magnetic Resonance in Medicine, Vol.3. New York, USA:SMRM; 1993:1544.
  • 44) Charles, H. C.;Lazeyras, F.;Krishnan. R. K. K, et al. Brain choline in depression:In vivo detection of potential pharmacodynamic effects of antidepressant therapy using hydrogen localized spectroscopy. In:Book of Abstracts:Eleventh Annual Scientific Meeting of the Society of Magnetic Resonance in Medicine, Vol.1. Berlin, Germany:SMRM; 1992:757
  • 46) Renshaw, P. F.; Stoll, A. L; Rothschild, A. et al. Proton MRS studies of the basal ganglia in major depression:Side and treatment effects. In:Proceeding:Twelfth Annual Scientific Meeting of the Society of Magnetic Resonance in Medicine, Vol.1. New York, USA:SMRM; 1993:433.
  • 47) Kato. T.; Hamakawa. H.; Shioiri, T, et al. Proton MRS of the basal ganglia in patients with bipolar disorder. In:Proceeding:Second Meeting of the Society of Magnetic Resonance, Vol.2. San Francisco, California USA:SMR; 1994:605.
  • 48) Bruhn, H.;Stoppe. G;Staedt, J. et al. Quantitative proton MRS in vivo shows cerebral myo-inositol and cholines to be unchanged in manic-depressive patients treated with lithium. In:Proceeding:Twelfth Annual Scientific Meeting of the Society of Magnetic Resonance in Medicine, Vol.3. New York, USA:SMRM; 1993:1543.
  • 50) Yamaguchi, H.; Uchida, T.; Fujimoto, T, et al. 1H MRS findings of brains in patients with alcoholism. Japanese Journal of Psychiatric Research on Alcohol 3:49-54; 1996. [Japanese]
  • 51) Gibbs, S. J.:Riddle, W:R.:Welch, L. W. et al. Recovery of brain function in newly abstinent alcoholics:Correlation with proton single voxel spectroscopy. In:Proceedings:Third Scientific Meeting and Exhibition of the Society of Magnetic Resonance, Vol.1. Nice, France:SMR:1995:61,
  • 52) Fujimoto, T.:Uchida, T.:Yamaguchi, H. et al. 1H MRS study of temporal lobe in alcoholic patients. In:Abstracts of the X World Congress of Psychiatry, Vol.2. Madrid; 1996:130.
  • 53) Fujimoto, T.:Uchida, T.:Yamaguchi. H. et al. Localized 1H MRS in alcoholic dementia. In:Proceedings:Fourth Scientific Meeting and Exhibition of the International Society for Magnetic Resonance in Medicine, Vol.2. New York, USA:ISMRM; 1996:952.
  • 54) Behar. K.:Rothman. D.:Petersen, K. et al. Cortical GABA levels are reduced in localized 1H NMR spectra of alcoholic and hepatic encephalopathy patients. In:Proceedings:Fourth Scientific Meeting and Exhibition of the International Society for Magnetic Resonance in Medicine, Vol.1. New York, USA:ISMRM; 1996:408.
  • 58) Chiu, T.-M.:Woods, B:T.;Teoh, S, K, et al. Proton spectroscopy of brain alcohol signals at short echo times in alcohol-tolerant and alcohol non-tolerant human subjects. In:Book of Abstracts:Eleventh Annual Scientific Meeting of the Society of Magnetic Resonance in Medicine, Berlin, Germany:SMRM; 1992:1958.
はじめての方へ
個人／法人会員登録のご案内